Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Insider activity
View:
Post by jeffm34 on Jun 02, 2021 11:58am

Insider activity

Andrew Molson and his brothers are worth billions. They even own the Montreal Canadians. You would think at least he might be able to step up and buy a few shares with his own money and show someone in management still believes in this company.  I guess why would he do that when he has his risk free stock option plan.
Comment by Bucknelly21 on Jun 02, 2021 12:03pm
It appears that the new plan to get people interested is not taking shape in the way that we thought
Comment by qwerty22 on Jun 02, 2021 12:18pm
Nothing has happened commercially, clinically, scientifically or financially since the AGM, it may not happen until late summer.  
Comment by scarlet1967 on Jun 02, 2021 1:13pm
The plan was supposed to incorporate shareholder communication, during the chat with Ed Nash Paul revealed few important details such as they will dose first patient for NASH in September, they don't see any issues with the agencies, Tesamorelin might not be the first drug for the condition but the best, as they don't have the sale force capable of commercializing the drug they might ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities